UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Metabolomic Fingerprints of Medical Therapy Versus Bariatric Surgery in Patients With Obesity and Type 2 Diabetes: The STAMPEDE Trial

Diabetes care, 2024-11, Vol.47 (11), p.2024-2032

2024

Volltextzugriff (PDF)

Microtopographic Variation as a Potential Early Indicator of Ecosystem State Change and Vulnerability in Salt Marshes

Estuaries and coasts, 2024-11, Vol.47 (7), p.2120-2134

2024

Volltextzugriff (PDF)

Effect of sodium–glucose co-transporter-2 inhibitors on survival free of organ support in patients hospitalised for COVID-19 (ACTIV-4a): a pragmatic, multicentre, open-label, randomised, controlled, platform trial

The lancet. Diabetes & endocrinology, 2024-10, Vol.12 (10), p.725-734

2024

Volltextzugriff (PDF)

P2.11A.04 Exhaled Breath Biomarkers of Response to Immunotherapy in Advanced Non-Small Lung Cancer

Journal of thoracic oncology, 2024-10, Vol.19 (10), p.S253-S254

2024

Volltextzugriff (PDF)

Early detection of invasive Phragmites australis at the tidal marsh-forest ecotone with airborne LiDAR

Ecological indicators, 2024-10, Vol.167, p.112651, Article 112651

2024

Volltextzugriff (PDF)

Feedbacks Regulating the Salinization of Coastal Landscapes

Annual review of marine science, 2024-09

2024

Volltextzugriff (PDF)

Bioenergetic Atlas of Small Intestinal Mucosal Mitochondria

Biochimica et biophysica acta. Bioenergetics, 2024-09, Vol.1865, p.149354, Article 149354

2024

Volltextzugriff (PDF)

The AAHKS Clinical Research Award: Extended Postoperative Oral Tranexamic Acid in Total Knee Arthroplasty: A Randomized Controlled Pilot Study

The Journal of arthroplasty, 2024-09, Vol.39 (9), p.S13-S17

2024

Volltextzugriff (PDF)

146 Liver disease outcomes in people with cystic fibrosis after 2 years of elexacaftor/tezacaftor/ivacaftor—results from the RECOVER trial

Journal of cystic fibrosis, 2024-09, Vol.23, p.S81-S82

2024

Volltextzugriff (PDF)

126 Adherence to elexacaftor/tezacaftor/ivacaftor and clinical outcomes in people with cystic fibrosis—the RECOVER study

Journal of cystic fibrosis, 2024-09, Vol.23, p.S69-S69

2024

Volltextzugriff (PDF)

A grazing crab drives saltmarsh carbon storage and recovery

Ecology (Durham), 2024-09, Vol.105 (9), p.e4385-n/a

2024

Volltextzugriff (PDF)

142 Clinical outcomes after 2 years of treatment with elexacaftor/tezacaftor/ivacaftor in children aged 6 to −11 with cystic fibrosis—The RECOVER Study

Journal of cystic fibrosis, 2024-09, Vol.23, p.S78-S79

2024

Volltextzugriff (PDF)

A response time model of the three-choice Mnemonic Similarity Task provides stable, mechanistically interpretable individual-difference measures

Frontiers in human neuroscience, 2024-08, Vol.18, p.1379287

2024

Volltextzugriff (PDF)

Best Practices for Microbial Challenge In-Use Studies to Evaluate the Microbial Growth Potential of Parenteral Biological Products; Industry and Regulatory Considerations

PDA journal of pharmaceutical science and technology, 2024-08, Vol.78 (4), p.475-500

2024

Volltextzugriff (PDF)

The bioenergetic landscape of cancer

Molecular metabolism (Germany), 2024-08, Vol.86, p.101966, Article 101966

2024

Volltextzugriff (PDF)

Temporal dynamics of in vitro hemostatic function in platelets cryopreserved using a novel approach for rapid issuance

Transfusion (Philadelphia, Pa.), 2024-07, Vol.64 (7), p.1287-1295

2024

Volltextzugriff (PDF)

P108 Describing trends in cystic fibrosis transmembrane conductance regulator modulator (CFTRm) use in people with cystic fibrosis (PwCF) using real-world Cystic Fibrosis Registry of Ireland (CFRI) data

Journal of cystic fibrosis, 2024-06, Vol.23, p.S118-S118

2024

Volltextzugriff (PDF)

WS13.01 Proteomic analysis of nasal lavage fluid samples in people with cystic fibrosis after one year of treatment with elexacaftor/ivacaftor/tezacaftor – the RECOVER study

Journal of cystic fibrosis, 2024-06, Vol.23, p.S23-S24

2024

Volltextzugriff (PDF)

P124 Assessment of the impact of the newborn screening programme on lung function in children with cystic fibrosis in Ireland: The Irish Comparative Outcomes Study (ICOS)

Journal of cystic fibrosis, 2024-06, Vol.23, p.S123-S123

2024

Volltextzugriff (PDF)

EPS6.04 Getting ready for the storm: what cardiovascular disease metrics do national cystic fibrosis registries currently collect?

Journal of cystic fibrosis, 2024-06, Vol.23, p.S51-S51

2024

Volltextzugriff (PDF)

P057 Measuring adherence to chronic therapies over the first year of treatment with elexacaftor/tezacaftor/ivacaftor (ETI) in people with cystic fibrosis (CF) aged 6–11 years – the RECOVER study

Journal of cystic fibrosis, 2024-06, Vol.23, p.S84-S84

2024

Volltextzugriff (PDF)

Litter Decomposition in Retreating Coastal Forests

Estuaries and coasts, 2024-06, Vol.47 (4), p.1139-1149

2024

Volltextzugriff (PDF)

P130 Developing a study protocol to assess the feasibility and acceptability of implementing patient reported outcome measures in the Cystic Fibrosis Registry of Ireland

Journal of cystic fibrosis, 2024-06, Vol.23, p.S125-S125

2024

Volltextzugriff (PDF)

EPS4.02 Exploring barriers to treatment adherence in people with cystic fibrosis: insights from the RECOVER study at 24 months

Journal of cystic fibrosis, 2024-06, Vol.23, p.S44-S44

2024

Volltextzugriff (PDF)

WS15.05 Improvements in structural lung disease in people with CF aged 12 and above on elexacaftor/tezacaftor/ivacaftor are sustained for up to two years

Journal of cystic fibrosis, 2024-06, Vol.23, p.S29-S29

2024

Volltextzugriff (PDF)

1 – 25 von 1.113

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(974)
Mit Volltextzugriff
(941)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(13)

Menü

Weitere Dienste

Einstellungen

Metabolomic Fingerprints of Medical Therapy Versus Bariatric Surgery in Patients With Obesity and Type 2 Diabetes: The STAMPEDE Trial

Microtopographic Variation as a Potential Early Indicator of Ecosystem State Change and Vulnerability in Salt Marshes

Effect of sodium–glucose co-transporter-2 inhibitors on survival free of organ support in patients hospitalised for COVID-19 (ACTIV-4a): a pragmatic, multicentre, open-label, randomised, controlled, platform trial

P2.11A.04 Exhaled Breath Biomarkers of Response to Immunotherapy in Advanced Non-Small Lung Cancer

Early detection of invasive Phragmites australis at the tidal marsh-forest ecotone with airborne LiDAR

Feedbacks Regulating the Salinization of Coastal Landscapes

Bioenergetic Atlas of Small Intestinal Mucosal Mitochondria

The AAHKS Clinical Research Award: Extended Postoperative Oral Tranexamic Acid in Total Knee Arthroplasty: A Randomized Controlled Pilot Study

146 Liver disease outcomes in people with cystic fibrosis after 2 years of elexacaftor/tezacaftor/ivacaftor—results from the RECOVER trial

126 Adherence to elexacaftor/tezacaftor/ivacaftor and clinical outcomes in people with cystic fibrosis—the RECOVER study

A grazing crab drives saltmarsh carbon storage and recovery

142 Clinical outcomes after 2 years of treatment with elexacaftor/tezacaftor/ivacaftor in children aged 6 to −11 with cystic fibrosis—The RECOVER Study

A response time model of the three-choice Mnemonic Similarity Task provides stable, mechanistically interpretable individual-difference measures

Best Practices for Microbial Challenge In-Use Studies to Evaluate the Microbial Growth Potential of Parenteral Biological Products; Industry and Regulatory Considerations

The bioenergetic landscape of cancer

Temporal dynamics of in vitro hemostatic function in platelets cryopreserved using a novel approach for rapid issuance

P108 Describing trends in cystic fibrosis transmembrane conductance regulator modulator (CFTRm) use in people with cystic fibrosis (PwCF) using real-world Cystic Fibrosis Registry of Ireland (CFRI) data

WS13.01 Proteomic analysis of nasal lavage fluid samples in people with cystic fibrosis after one year of treatment with elexacaftor/ivacaftor/tezacaftor – the RECOVER study

P124 Assessment of the impact of the newborn screening programme on lung function in children with cystic fibrosis in Ireland: The Irish Comparative Outcomes Study (ICOS)

EPS6.04 Getting ready for the storm: what cardiovascular disease metrics do national cystic fibrosis registries currently collect?

P057 Measuring adherence to chronic therapies over the first year of treatment with elexacaftor/tezacaftor/ivacaftor (ETI) in people with cystic fibrosis (CF) aged 6–11 years – the RECOVER study

Litter Decomposition in Retreating Coastal Forests

P130 Developing a study protocol to assess the feasibility and acceptability of implementing patient reported outcome measures in the Cystic Fibrosis Registry of Ireland

EPS4.02 Exploring barriers to treatment adherence in people with cystic fibrosis: insights from the RECOVER study at 24 months

WS15.05 Improvements in structural lung disease in people with CF aged 12 and above on elexacaftor/tezacaftor/ivacaftor are sustained for up to two years

Suchergebnisse filtern